Nuclear localization of AhR has been reported to be more common in lung cancer from women, non-smokers, adenocarcinoma and NSCLC patients with the EGFR exon 19 (E746–750A) deletion [114]. The gene discussed is AHR; the disease is adenocarcinoma.